Evidence map›Paper›PMID 35578085›Full record

ReviewCerebellum (London, England)2022

Cell-Autonomous Processes That Impair Xenograft Survival into the Cerebellum.

Lorenzo Magrassi, Giulia Nato, Domenico Delia, Annalisa Buffo

Open access · hybridAbstract readReview
In one paragraph

Review in Cerebellum (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Lorenzo MagrassiNeurosurgery, Department of Clinical, Surgical, Diagnostic and Pediatric Science, University of Pavia, Foundation IRCCS Policlinico San Matteo, Pavia, Italy. lorenzo.magrassi@unipv.it.ORCID http://orcid.org/0000-0002-8308-2720
Giulia NatoNeuroscience Institute Cavalieri Ottolenghi (NICO), Orbassano, 10043, Torino, Italy.
Domenico DeliaIFOM, FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milano, Italy.
Annalisa BuffoNeuroscience Institute Cavalieri Ottolenghi (NICO), Orbassano, 10043, Torino, Italy.
Accademia Albertina delle Belle Arti · ITIFOM · ITNeuroscience Institute · ITUniversity of Pavia · IT

Funding

Fondazione IRCCS Policlinico San Matteo 08016019
6 · The paper itself

Abstract

In immunocompetent animals, numerous factors including the immune system of the host regulate the survival of neuro-glial precursors transplanted into the cerebellum. We transplanted human neuro-glial precursors derived in vitro from partial differentiation of IPS cells into the developing cerebellum of mice and rats before maturation of the host immune system. These approaches should facilitate the development of immune-tolerance for the transplanted cells. However, we found that human cells survived the engraftment and integrated into the host cerebellum and brain stem up to about 1 month postnatally when they were rejected in both species. On the contrary, when we transplanted the same cells in NOD-SCID mice, they survived indefinitely. Our findings are consistent with the hypothesis that the slower pace of differentiation of human neural precursors compared to that of rodents restricts the induction of immune-tolerance to human antigens expressed before completion of the maturation of the immune system. As predicted by our hypothesis, when we engrafted the human neuro-glial precursor cells either in a more mature state or mixed with extracts from adult cerebellum, we prolonged the survival of the graft.

Indexed as

CerebellumAnimalsHeterograftsHumansMiceMice, Inbred NODMice, SCIDRatsTransplantation, HeterologousCerebellumImmune-toleranceInduced pluripotent stem cellsXenotransplantation

Identifiers

PMID35578085
PMCPMC9411236
OpenAlexW4280525159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.